Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Silverman

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Clinical Chemistry|August 1, 1979
Creatine kinase BB: a new tumor-associated markerL M Silverman, G B Dermer, M H Zweig, et al.
The Journal of Urology|June 1, 1984
In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor sublineA S Wenger, D D Mickey, M Hall, et al.
Clinical Chemistry|October 1, 1994
Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patientG J Tsongalis, G Faber, F G Dalldorf, et al.
Gastroenterology|December 1, 2001
Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutationsP G Noone, Z Zhou, L M Silverman, et al.
The Prostate|January 1, 1981
Creatine kinase BB and other markers of prostatic carcinomaL M Silverman, J F Chapman, M E Jones, et al.
Clinical Chemistry|October 1, 1990
A model for molecular screening of newborns: simultaneous detection of Duchenne/Becker muscular dystrophies and cystic fibrosisT W Prior, W E Highsmith, K J Friedman, et al.
Clinical Chemistry|January 1, 1997
Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesisE M Rohlfs, W G Learning, K J Friedman, et al.
Archives of Pathology & Laboratory Medicine|December 3, 1999
HFE genotyping using multiplex allele-specific polymerase chain reaction and capillary electrophoresisI M Lubin, N A Yamada, R M Stansel, et al.
The New England Journal of Medicine|September 3, 1998
Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitisJ A Cohn, K J Friedman, P G Noone, et al.
Human Genetics|December 29, 2000
In-frame deletions of BRCA1 may define critical functional domainsE M Rohlfs, C H Chung, Q Yang, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|August 1, 1979
Creatine kinase BB: a new tumor-associated markerL M Silverman, G B Dermer, M H Zweig, et al.
The Journal of Urology|June 1, 1984
In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor sublineA S Wenger, D D Mickey, M Hall, et al.
Clinical Chemistry|October 1, 1994
Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patientG J Tsongalis, G Faber, F G Dalldorf, et al.
Gastroenterology|December 1, 2001
Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutationsP G Noone, Z Zhou, L M Silverman, et al.
The Prostate|January 1, 1981
Creatine kinase BB and other markers of prostatic carcinomaL M Silverman, J F Chapman, M E Jones, et al.
Clinical Chemistry|October 1, 1990
A model for molecular screening of newborns: simultaneous detection of Duchenne/Becker muscular dystrophies and cystic fibrosisT W Prior, W E Highsmith, K J Friedman, et al.
Clinical Chemistry|January 1, 1997
Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesisE M Rohlfs, W G Learning, K J Friedman, et al.
Archives of Pathology & Laboratory Medicine|December 3, 1999
HFE genotyping using multiplex allele-specific polymerase chain reaction and capillary electrophoresisI M Lubin, N A Yamada, R M Stansel, et al.
The New England Journal of Medicine|September 3, 1998
Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitisJ A Cohn, K J Friedman, P G Noone, et al.
Human Genetics|December 29, 2000
In-frame deletions of BRCA1 may define critical functional domainsE M Rohlfs, C H Chung, Q Yang, et al.
Pageof 9